Ovarian & Breast Cancer: Genomic-Guided Combination Therapy

feeds has 409 videos Subscribe Here

Description: The strategy involves multi-platform technology and the use of specific algorithms to decide which combinations of drugs would best suit a particular patient, he explains in the interview.

The aim is to hopefully show regulatory agencies, health authorities and medical insurance companies that the addition of genomic-guided therapy to standard therapy in early stage disease can transform the outcome of therapy.

Dr Leyland-Jones talks to ecancertv at WIN 2015 discussing his presentation ‘Personalised combatorial approaches to closing down all the key oncogenic drivers’ given.
Shared By : feeds
Posted on : 07/21/15
Added : 4 years ago
Category : Breast Cancer